Pitavastatin and Chronic obstructive pulmonary disease - a phase IV clinical study of FDA data

Summary:

Chronic obstructive pulmonary disease is reported as a side effect among people who take Pitavastatin (pitavastatin), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Omega-3 Fatty Acids, and have Bronchitis.

The phase IV clinical study analyzes which people have Chronic obstructive pulmonary disease when taking Pitavastatin. It is created by eHealthMe based on reports of 1,896 people who have side effects when taking Pitavastatin from the FDA, and is updated regularly.

What is Pitavastatin?

Pitavastatin has active ingredients of pitavastatin. It is often used in high blood cholesterol. eHealthMe is studying from 1,914 Pitavastatin users. Check the latest studies of Pitavastatin.

What is Chronic obstructive pulmonary disease?

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe) is found to be associated with 1,808 drugs and 2,206 conditions by eHealthMe. Check the latest studies of Chronic obstructive pulmonary disease.

On Jul, 12, 2026

1,896 people reported to have side effects when taking Pitavastatin.
Among them, 18 people (0.95%) have Chronic obstructive pulmonary disease.

Could Pitavastatin cause Chronic obstructive pulmonary disease?

Among these 18 people:

How long have people been on Pitavastatin when they have Chronic obstructive pulmonary disease? *

What is the gender of people who have Chronic obstructive pulmonary disease when taking Pitavastatin? *

female: 5.56 %
male: 94.44 %

What is the age of people who have Chronic obstructive pulmonary disease when taking Pitavastatin? *

What are other drugs people take besides Pitavastatin? *

Vitamin D3: 13 people, 72.22%
Magnesium: 13 people, 72.22%
Omega-3 Fatty Acids: 13 people, 72.22%
Amiodarone Hydrochloride: 9 people, 50.00%
Aspirin: 9 people, 50.00%
Ticagrelor: 9 people, 50.00%
Ezetimibe: 9 people, 50.00%
Garlic: 9 people, 50.00%
Moxifloxacin Hydrochloride: 9 people, 50.00%
Simvastatin: 9 people, 50.00%

What are other side effects people have besides Chronic obstructive pulmonary disease? *

Dyspnea (difficult or laboured breathing): 18 people, 100.00%
Fever: 16 people, 88.89%
Fatigue (feeling of tiredness): 16 people, 88.89%
Weakness: 14 people, 77.78%
Malaise (a feeling of general discomfort or uneasiness): 14 people, 77.78%
Cough: 14 people, 77.78%
Drug Intolerance (drug sensitivity): 13 people, 72.22%
Viral Infection: 13 people, 72.22%
Heart Attack: 13 people, 72.22%
Head Injury: 13 people, 72.22%

What are the existing conditions these people have? *

Fever: 13 people, 72.22%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 13 people, 72.22%
High Blood Pressure: 8 people, 44.44%
Psoriasis (immune-mediated disease that affects the skin): 4 people, 22.22%
Hypertensive Heart Disease: 4 people, 22.22%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 22.22%
Diabetes: 4 people, 22.22%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 4 people, 22.22%
Enlarged Prostate: 2 people, 11.11%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Pitavastatin and have Chronic obstructive pulmonary disease?

- Check whether Chronic obstructive pulmonary disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pitavastatin:

Pitavastatin (1,914 reports)

Browse all side effects of Pitavastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chronic obstructive pulmonary disease:

Chronic obstructive pulmonary disease (1,808 drugs)

Browse all the conditions that are associated with Chronic obstructive pulmonary disease:

Chronic obstructive pulmonary disease (2,206 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pitavastatin (the active ingredients of Pitavastatin) and Pitavastatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.